NEI
Northwest & Ethical Investments Portfolio holdings
AUM
$4.03B
1-Year Return
20.27%
This Quarter Return
-2.9%
1 Year Return
+20.27%
3 Year Return
+68.59%
5 Year Return
+133.3%
10 Year Return
+253.02%
AUM
$1.49B
AUM Growth
-$49.7M
(-3.2%)
Cap. Flow
+$1.88M
Cap. Flow
% of AUM
0.13%
Top 10 Holdings %
Top 10 Hldgs %
19.67%
Holding
379
New
31
Increased
128
Reduced
132
Closed
27
Top Buys
| 1 |
Nutrien
NTR
|
+$23.1M |
| 2 |
Cenovus Energy
CVE
|
+$13.2M |
| 3 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$5.24M |
| 4 |
Sealed Air
SEE
|
+$4.08M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$4.04M |
Top Sells
| 1 |
AGU
Agrium
AGU
|
+$20.5M |
| 2 |
RB Global
RBA
|
+$16.5M |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
+$5.52M |
| 4 |
Microsoft
MSFT
|
+$5.49M |
| 5 |
Suncor Energy
SU
|
+$5.13M |
Sector Composition
| 1 | Financials | 24.68% |
| 2 | Industrials | 12.9% |
| 3 | Technology | 9.74% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Healthcare | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Fortune Brands Innovations
FBIN
$7.05B
| $165K | 0.01% |
3,276
+702
| +27% | +$35.3K |
|
327
Vail Resorts
MTN
$5.37B
| $164K | 0.01% |
738
+100
| +16% | +$22.2K |
|
|
LM
328
DELISTED
Legg Mason, Inc.
LM
| $163K | 0.01% |
4,000
+700
| +21% | +$28.5K |
|
329
JetBlue
JBLU
$1.85B
| $161K | 0.01% |
7,900
+1,700
| +27% | +$34.5K |
|
330
Medtronic
MDT
$118B
| $152K | 0.01% |
1,900
| – | – |
|
331
Bio-Rad Laboratories Class A
BIO
$7.49B
| $150K | 0.01% |
+600
| New | +$150K |
|
|
HRC
332
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $148K | 0.01% |
+1,700
| New | +$148K |
|
|
NVRO
333
DELISTED
NEVRO CORP.
NVRO
| $147K | 0.01% |
1,700
+400
| +31% | +$34.7K |
|
334
Texas Roadhouse
TXRH
$11B
| $144K | 0.01% |
2,500
-400
| -14% | -$23.1K |
|
335
Edwards Lifesciences
EW
$46B
| $143K | 0.01% |
3,075
| – | – |
|
336
Thor Industries
THO
$5.66B
| $138K | 0.01% |
1,200
+200
| +20% | +$23K |
|
337
PJT Partners
PJT
$4.37B
| $130K | 0.01% |
2,593
| – | – |
|
|
BID
338
DELISTED
Sotheby's
BID
| $118K | 0.01% |
+2,300
| New | +$118K |
|
|
ABMD
339
DELISTED
Abiomed Inc
ABMD
| $116K | 0.01% |
400
-300
| -43% | -$87.3K |
|
340
Hyatt Hotels
H
$13.6B
| $114K | 0.01% |
1,500
-800
| -35% | -$61K |
|
341
Jazz Pharmaceuticals
JAZZ
$7.7B
| $106K | 0.01% |
+700
| New | +$106K |
|
342
Intuitive Surgical
ISRG
$161B
| $104K | 0.01% |
756
| – | – |
|
343
BioMarin Pharmaceuticals
BMRN
$10.5B
| $97.3K | 0.01% |
1,200
+400
| +50% | +$32.4K |
|
344
Neurocrine Biosciences
NBIX
$14B
| $91.2K | 0.01% |
+1,100
| New | +$91.2K |
|
|
ATTO
345
DELISTED
Atento S.A.
ATTO
| $86.3K | 0.01% |
2,202
| – | – |
|
346
Biogen
BIIB
$20.9B
| $82.1K | 0.01% |
300
| – | – |
|
|
CELG
347
DELISTED
Celgene Corp
CELG
| $80.3K | 0.01% |
900
-11,255
| -93% | -$1M |
|
348
Incyte
INCY
$16.8B
| $79.7K | 0.01% |
956
+200
| +26% | +$16.7K |
|
349
Align Technology
ALGN
$9.64B
| $74.8K | 0.01% |
298
| – | – |
|
|
CLVS
350
DELISTED
Clovis Oncology, Inc.
CLVS
| $73.9K | 0.01% |
+1,400
| New | +$73.9K |
|